Funder: European Commission
Due Dates: September 16, 2025 (Full application submission deadline)
Funding Amounts: €6–8 million per project | ~4 grants awarded | Lump sum funding
Summary: Supports multinational early-stage clinical trials to develop innovative, targeted, and less toxic cancer treatments for children and adolescents, fostering collaboration and open science in paediatric oncology.
Key Information: Proposals must address both children (0–14) and/or adolescents (15–19) and require cross-sectoral, multidisciplinary consortia.